1-[(2,5-Dibromothieno[2.3-b]thien-3-yl)methyl]-3-{[(4-fluorophenyl)sulfonyl]methyl}azetidine → HCID 21978412, compound
Reaction equation
Br[C:2]1[S:10][C:5]2[S:6][C:7](Br)=[CH:8][C:4]=2[C:3]=1[CH2:11][N:12]1[CH2:15][CH:14]([CH2:16][S:17]([C:20]2[CH:25]=[CH:24][C:23]([F:26])=[CH:22][CH:21]=2)(=[O:19])=[O:18])[CH2:13]1.[H][H]>[Pd].CO>[F:26][C:23]1[CH:24]=[CH:25][C:20]([S:17]([CH2:16][CH:14]2[CH2:15][N:12]([CH2:11][C:3]3[C:4]4[CH:8]=[CH:7][S:6][C:5]=4[S:10][CH:2]=3)[CH2:13]2)(=[O:19])=[O:18])=[CH:21][CH:22]=1Participants
Procedure
A mixture of 1-[(2,5-dibromothieno[2.3-b]thien-3-yl)methyl]-3-{[(4-fluorophenyl)sulfonyl]methyl}azetidine (Step 4, 39 mg, 0.07 mmol) and 10% palladium on carbon (50 mg) in methanol (7 mL) was stirred under a balloon of hydrogen for 3.5 hours. The catalyst was removed by filtration through Celite®, washing with methanol after the addition of triethylamine (30 μL) to quench any HBr formed. The filtrate was concentrated in vacuo. The residue was purified by preparative TLC (50% ethyl acetate/isohexane) to give the title compound (2.5 mg). 1H NMR (500 MHz, CDCl3) δ 7.91–7.89 (2H, m), 7.34 (1H, dd, J=1.0, 5.2 Hz), 7.23 (3H, t, J=7.3 Hz), 7.10 (1H, s), 3.70 (2H, s), 3.47 (2H, t, J=7.3 Hz), 3.38 (2H, d, J=7.3 Hz), 2.96 (2H, br s), 2.88–2.82 (1H, m).
Workup
- customThe catalyst was removed by filtration through Celite®
- washwashing with methanol
- additionafter the addition of triethylamine (30 μL)
- customto quench any HBr
- customformed
- concentrationThe filtrate was concentrated in vacuo
- customThe residue was purified by preparative TLC (50% ethyl acetate/isohexane)
Sources & evidence
- ORD record
- ord-96fd61fe2c3244a199b4f9c341d9513b
- Source dataset
- uspto-grants-2006_08
- Patent number
- US07094777B2
Reaction notes
Loading…